Lonza Opens Cell and Gene Therapy Mfg. Facility
Nutriband Acquires 4P Therapeutics
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF India to Shut Two Dahej Care Chemicals Plants as Overcapacity Squeezes Margins
-
LANXESS Specialty Additives Earnings Jump 32.8%, but Chemical Demand Recovery Remains Elusive
-
BASF Brings Biomass-Balance Polyols to North America
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
Recommend Reading
-
BASF Raises API and Excipient Prices
-
Another Strategic Move! DuPont Launches a New Specialty Lubricants Project in Zhangjiagang
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
Premium Global Chemical Sourcing Requests (12 - 16 Mar, 2026)
-
Business Society’s Market Outlook for Hydrogen Peroxide on August 17, 2026: Bearish
-
Business Society’s Market Outlook for MIBK on August 18, 2026: Volatile and Tending to Weaken
-
Business Society’s Market Outlook for Caustic Soda on August 17, 2026: Narrow-Range Fluctuations